These presentations, interviews, and panel discussions took place at the 2019 CPhI bioLive Theater. Focusing on technology strategies for biopharmaceutical manufacturing, emerging therapies, and tools for process optimization that will be of interest to BPI readers and the CPhI attendees. Speakers highlighted manufacturing bottlenecks, new technologies to overcome those obstacles, and ADCs and bioconjugates. View the full presentations at the links below.

Industry’s Uptake of Single-Use Technology and How it Has Driven Vendor Consolidation: A Business Journalist’s Point of View

Single-Use Technology for Containment During ADC Handling

How Has Single-Use Increased Access to Biomanufacturing Solutions for Both CDMOs and End-Users?

Reducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody Drug Conjugates

Biopharmaceutical Indications and Targets: Past, Present, and Future

Bioconjugation CMC: Successfully Executing a Complex Process

How Are Service Companies Responding to the Increased Interest in New Modalities, and What Regulatory and Market Hurdles Still Exist?

CMC Considerations for Commercial-Ready ADC Manufacturing Processes to Enable Accelerated Timelines

Commercialization Frameworks for the Biopharma Ecosystem

Scaling Multi-Column Chromatography to the Production Suite

Where Are Today’s Biomanufacturing Bottlenecks and How Is Industry Looking to Overcome Them?

Flow-Through Polishing and the Use of Multimode Ligand Libraries to Improve Process Efficiencies

China’s Focus on Innovation: Investment in Product and Process Development — Innovative Technologies from China are Coming

Biopharma as a Maturing Industry

At What Point in Drug Development Must a Firm Look to Process Optimization, and How Critical is this Timing to a Product’s Overall Success?